SuperGen, Inc. has entered into a definitive agreement to acquire Montigen Pharmaceuticals, Inc., a privately held oncology-focused drug discovery and development company headquartered in Salt Lake City, UT. Montigen’s assets include its R&D team, a proprietary drug discovery technology platform and optimization process, CLIMB, and late-stage pre-clinical compounds targeting aurora-A kinase and members of the tyrosine kinase receptor family. One of the Montigen compounds is expected to...